FDA Authorizes Use of Malaria Drugs for Coronavirus

The authorization is for two oral prescription drugs, hydroxychloroquine and chloroquine.

The Food and Drug Administration on Sunday granted an emergency authorization for two drugs, which are typically prescribed to treat malaria, to be used as treatments for the coronavirus.

The emergency-use authorization is for two oral prescription drugs, hydroxychloroquine and chloroquine, which are used primarily to treat malaria, but are now being investigated by federal agencies, including the National Institutes of Health and the Biomedical Advanced Research and Development Authority, as possible treatments for the coronavirus.


Powered by National Review